(NYSE: ELV) Elevance Health's forecast annual revenue growth rate of 4.57% is not forecast to beat the US Healthcare Plans industry's average forecast revenue growth rate of 5.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Elevance Health's revenue in 2024 is $171,340,000,000.On average, 13 Wall Street analysts forecast ELV's revenue for 2024 to be $40,106,335,783,515, with the lowest ELV revenue forecast at $39,811,481,908,380, and the highest ELV revenue forecast at $41,236,019,505,291. On average, 13 Wall Street analysts forecast ELV's revenue for 2025 to be $42,459,878,922,252, with the lowest ELV revenue forecast at $41,428,250,414,148, and the highest ELV revenue forecast at $44,656,087,041,677.
In 2026, ELV is forecast to generate $45,832,064,628,987 in revenue, with the lowest revenue forecast at $44,271,601,957,089 and the highest revenue forecast at $50,152,327,501,088.